semaglutide constipation lawsuit in louisiana glp-1 vomiting gastroparesis nausea law office Wegovy Over Louisiana Wegovy Lawsuit Lawyer glp-1 class louisiana semaglutide constipation attorney semaglutide

Efficacy differs measurably in trials, with semaglutide showing up to about 15% average body weight reduction over extended study periods versus roughly 9% average weight loss for liraglutide at 12 months

This determines which metabolic pathways are contributing to your weight resistance and which peptide approach will be most effective

Erdogdu O, Nathanson D, Sjoholm A, Nystrom T, Zhang Q: Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor

In this article, we explore the scientific evidence, the types of hair loss reported during treatment, and the biological mechanisms that might explain the connection, separating what research supports from what remains uncertain

The frequency and severity of gastrointestinal effects represent a significant clinical consideration